13D Filing: Sagard Capital Partners, L.P. and Jaguar Health Inc. (JAGX)

Page 2 of 25

Page 2 of 25 – SEC Filing

 

CUSIP No. 47010C201

 

 

1

Name of Reporting Person:
Sagard Capital Partners, L.P.
I.R.S. Identification No. of Above Person (Entities Only):  20-3332164

 

 

2

Check the Appropriate Box if a Member of a Group (See Instructions)

 

 

(a)

 o

 

 

(b)

 o

 

 

3

SEC Use Only

 

 

4

Source of Funds
WC

 

 

5

Check Box if Disclosure of Legal Proceedings Is Required Pursuant to Items 2(d) or 2(e)     o

 

 

6

Citizenship or Place of Organization
Delaware

 

Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With

7

Sole Voting Power:
0

 

8

Shared Voting Power:
49,724,330 Shares*

 

9

Sole Dispositive Power:
0

 

10

Shared Dispositive Power:
49,724,330 Shares*

 

 

11

Aggregate Amount Beneficially Owned by Each Reporting Person:
49,724,330 Shares *

 

 

12

Check Box if the Aggregate Amount in Row (11) Excludes Certain Shares  o

 

 

13

Percent of Class Represented by Amount in Row (11):
22.6% **

 

 

14

Type of Reporting Person:
PN

 


* Consists of 5,524,926 shares of Series A Convertible Participating Preferred Stock, par value $0.0001 per share, each of which is convertible into voting common stock of the Issuer (as defined herein) at the rate of approximately one share of Series A Convertible Participating Preferred Stock for 9 shares of voting common stock of the Issuer.

** Assumes the conversion of Series A Convertible Participating Preferred Stock into voting common stock of the Issuer and is based on 220,074,494 shares of voting common stock of the Issuer outstanding on April 2, 2018, calculated on an as-converted basis (based on information provided by the Issuer).

 

1


Follow Jaguar Health Inc. (NASDAQ:JAGX)

Page 2 of 25